MARINO, STRAM & ASSOCIATES LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,113 filers reported holding NOVARTIS A G in Q2 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
MARINO, STRAM & ASSOCIATES LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$454,811
-2.8%
4,465
-3.8%
0.13%0.0%
Q2 2023$468,127
+9.7%
4,639
+0.0%
0.13%
+3.1%
Q1 2023$426,595
+2.1%
4,637
+0.7%
0.13%
-2.3%
Q4 2022$417,817
+20.4%
4,606
+0.9%
0.13%
+5.6%
Q3 2022$347,000
-8.9%
4,565
+1.3%
0.12%
-5.3%
Q2 2022$381,000
+1.9%
4,505
+5.8%
0.13%
+11.9%
Q1 2022$374,000
+3.9%
4,259
+3.4%
0.12%
+6.3%
Q4 2021$360,000
-4.5%
4,117
-10.8%
0.11%
-14.6%
Q3 2021$377,000
-10.0%
4,614
-5.9%
0.13%
-20.7%
Q1 2021$419,000
-9.5%
4,904
+0.1%
0.16%
-20.4%
Q4 2020$463,000
+9.7%
4,901
+1.1%
0.21%
-8.4%
Q3 2020$422,000
-6.0%
4,850
-5.7%
0.22%
-15.7%
Q2 2020$449,000
+15.4%
5,145
+9.0%
0.27%
-11.0%
Q1 2020$389,000
-20.6%
4,720
-8.8%
0.30%
-6.5%
Q4 2019$490,000
+7.9%
5,174
-1.1%
0.32%
-0.3%
Q3 2019$454,000
-5.2%
5,229
-0.3%
0.32%
-8.3%
Q2 2019$479,000
-9.6%
5,247
-4.8%
0.35%
-8.1%
Q1 2019$530,000
+12.3%
5,510
+0.3%
0.38%
-7.3%
Q4 2018$472,000
-0.2%
5,496
+0.0%
0.41%
+8.7%
Q3 2018$473,000
+6.8%
5,494
-6.4%
0.38%
-3.8%
Q2 2018$443,000
-6.9%
5,869
-0.3%
0.39%
-10.5%
Q1 2018$476,000
-3.3%
5,885
+0.4%
0.44%
-3.1%
Q4 2017$492,0005,8600.45%
Other shareholders
NOVARTIS A G shareholders Q2 2021
NameSharesValueWeighting ↓
EXENCIAL WEALTH ADVISORS, LLC 188,514$13,713,0005.95%
PRENTISS SMITH & CO INC 136,441$10,133,0005.74%
MANAGED ASSET PORTFOLIOS, LLC 204,985$15,225,0005.46%
Osher Van de Voorde Investment Management 108,725$8,075,0004.40%
BROWN BROTHERS HARRIMAN & CO 10,796,684$801,870,0004.35%
SECTORAL ASSET MANAGEMENT INC 472,296$35,077,0004.10%
PROFESSIONAL ADVISORY SERVICES INC 235,347$17,479,0003.87%
Elefante Mark B 5,619$417,0003.78%
SPHERA FUNDS MANAGEMENT LTD. 255,000$18,959,0003.71%
CGOV Asset Management 997,161$98,662,0003.61%
View complete list of NOVARTIS A G shareholders